First Amendment to Prime Vendor AgreementPrime Vendor Agreement • August 19th, 2014 • Diplomat Pharmacy, Inc. • Retail-drug stores and proprietary stores
Contract Type FiledAugust 19th, 2014 Company IndustryThis First Amendment (“Amendment”) is entered into as of July 20, 2012 (“Effective Date”) by AmerisourceBergen Drug Corporation, a Delaware corporation (“ABDC”) on the one hand, and Diplomat Pharmacy, Inc., a Michigan corporation (“Diplomat”) for itself and on behalf of the following limited liability companies of which Diplomat is the sole member: Diplomat Specialty Pharmacy of Flint, LLC, Navigator Health Services, LLC, Diplomat Health Services, LLC, Diplomat Specialty Pharmacy of Grand Rapids, LLC, Diplomat Specialty Pharmacy of Chicago, LLC, Diplomat Specialty Pharmacy of Ft, Lauderdale, LLC, Diplomat Specialty Pharmacy of Swartz Creek, LLC and Diplomat Specialty Pharmacy of Southern California, LLC (Diplomat and such limited liability companies being referred to herein collectively as “Customer”) on the other hand. This Amendment amends the parties Prime Vendor Agreement dated January 1, 2012 (“PVA”). Capitalized terms not defined in this Amendment have the meaning set forth in th
FIRST AMENDMENT TO PHARMACY DISTRIBUTION AND SERVICES AGREEMENTPharmacy Distribution and Services Agreement • August 19th, 2014 • Diplomat Pharmacy, Inc. • Retail-drug stores and proprietary stores
Contract Type FiledAugust 19th, 2014 Company IndustryTHIS FIRST AMENDMENT TO PHARMACY DISTRIBUTION AND SERVICES AGREEMENT (“Amendment”) is made effective as of the 8th day of July, 2013(the “Effective Date”) between: Celgene Corporation, 86 Morris Avenue, Summit, New Jersey 07901 (together with its subsidiaries and affiliates hereinafter collectively referred to as “Celgene”), and Diplomat Specialty Pharmacy, 4100 South Saginaw Street, Flint, MI 48507 (together with its subsidiaries and affiliates hereinafter collectively referred to as “Pharmacy”).
ADOPTION AND AMENDMENT OF PHARMACY DISTRIBUTION AND SERVICES AGREEMENTPharmacy Distribution and Services Agreement • August 19th, 2014 • Diplomat Pharmacy, Inc. • Retail-drug stores and proprietary stores
Contract Type FiledAugust 19th, 2014 Company IndustryTHIS ADOPTION AND AMENDMENT OF PHARMACY DISTRIBUTION AND SERVICES AGREEMENT (“Agreement”) is effective March 21, 2014 (“Effective Date”) by and between Celgene Corporation (together with its subsidiaries and affiliates hereinafter collectively, “Celgene”) and Diplomat Pharmacy, Inc. d/b/a Diplomat Specialty Pharmacy (hereinafter, “Pharmacy”).
PRIME VENDOR AGREEMENTPrime Vendor Agreement • August 19th, 2014 • Diplomat Pharmacy, Inc. • Retail-drug stores and proprietary stores • Pennsylvania
Contract Type FiledAugust 19th, 2014 Company Industry JurisdictionThis Prime Vendor Agreement (“Agreement”) is made as of January 1, 2012 (“Effective Date”) by AmerisourceBergen Drug Corporation, a Delaware corporation (“ABDC”) on the one hand, and Diplomat Pharmacy, Inc., a Michigan corporation (“Diplomat”) for itself and on behalf of the following limited liability companies of which Diplomat is the sole member: Diplomat Specialty Pharmacy of Flint, LLC, Navigator Health Services, LLC, Diplomat Health Services, LLC, Diplomat Specialty Pharmacy of Grand Rapids, LLC, Diplomat Specialty Pharmacy of Chicago, LLC, Diplomat Specialty Pharmacy of Ft. Lauderdale, LLC, Diplomat Specialty Pharmacy of Swartz Creek, LLC and Diplomat Specialty Pharmacy of Southern California, LLC (Diplomat and such limited liability companies being referred to herein collectively as “Customer”) on the other hand.
VOTING AGREEMENTVoting Agreement • August 19th, 2014 • Diplomat Pharmacy, Inc. • Retail-drug stores and proprietary stores • Michigan
Contract Type FiledAugust 19th, 2014 Company Industry JurisdictionTHIS VOTING AGREEMENT (this “Agreement”) is made as of August 15, 2014, by and among Diplomat Pharmacy, Inc., a Michigan corporation (the “Company”), Philip R. Hagerman (“Majority Holder”) and the persons listed on the signature pages hereto (each, together with its successors, a “Shareholder” and collectively, the “Shareholders”).